Results 101 to 110 of about 1,361,736 (138)

Line Graph

2022
openaire   +1 more source

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study

Lancet, The, 2021
Jong-Mu Sun, Manish A Shah, Toshihiko Doi   +2 more
exaly  

Line Graph

2021
openaire   +1 more source

Immunotherapies for hepatocellular carcinoma

Nature Reviews Clinical Oncology, 2021
Josep M Llovet, Florian Castet, Mala K Maini   +2 more
exaly  

Hematology and oncology clinical care during the coronavirus disease 2019 pandemic

Ca-A Cancer Journal for Clinicians, 2020
Manish A Shah, Tsiporah B Shore, Sebastian Mayer   +2 more
exaly  

First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial

Lancet, The, 2021
Arnaud Scherpereel, Anna K Nowak, Nobukazu Fujimoto   +2 more
exaly  

Epithelial ovarian cancer: Evolution of management in the era of precision medicine

Ca-A Cancer Journal for Clinicians, 2019
Stephanie Lheureux, Marsela Braunstein, Amit M Oza   +2 more
exaly  

Cancer Disparities by Race/Ethnicity and Socioeconomic Status

Ca-A Cancer Journal for Clinicians, 2004
Gopal K Singh
exaly  

Line Graphs and Line Digraphs

2021
Lowell W. Beineke, Jay S. Bagga
openaire   +1 more source

Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa‐associated lymphoid tissue (MALT lymphoma)

Ca-A Cancer Journal for Clinicians, 2016
Markus Raderer, Barbara Kiesewetter
exaly